كاتادولون PR إسرائيل - العربية - Ministry of Health

كاتادولون pr

salomon,levin & elstein ltd - flupirtine maleate 400 mg - tablets prolonged release - flupirtine - for use in acute and chronic pain, e.g. painful muscular tension in the postural and locomotor muscles .

دوﻧپيزيل تيڤع ١٠ ملغ إسرائيل - العربية - Ministry of Health

دوﻧپيزيل تيڤع ١٠ ملغ

teva pharmaceutical indust.ltd - donepezil hydrochloride 5 mg - tablets - donepezil - treatment of mild to moderately severe alzheimer's dementia.

سالبوتامول تيڤع منشقة إسرائيل - العربية - Ministry of Health

سالبوتامول تيڤع منشقة

salomon,levin & elstein ltd - salbutamol as sulfate 100 mcg/dose - inhaler, cfc free - salbutamol - relief of bronchospasm in bronchial asthma of all types, chronic bronchitis and emphysema.

اتروڤنت إسرائيل - العربية - Ministry of Health

اتروڤنت

boehringer ingelheim israel ltd. - ipratropium bromide 0.02 mg - inhaler - ipratropium bromide - for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.

مونتيلوكاست تيڤع ۱٠ ملغ إسرائيل - العربية - Ministry of Health

مونتيلوكاست تيڤع ۱٠ ملغ

teva pharmaceutical indust.ltd - montelukast as sodium 10 mg - tablets - montelukast - montelukast teva is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. montelukast teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast teva is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and adolescents 15 years of age and older.

تلفست ١٨٠ ملغ إسرائيل - العربية - Ministry of Health

تلفست ١٨٠ ملغ

sanofi - aventis israel ltd - fexofenadine hydrochloride 180 mg - film coated tablets - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria.

تلفست ١٨٠ ملغ إسرائيل - العربية - Ministry of Health

تلفست ١٨٠ ملغ

sanofi - aventis israel ltd - fexofenadine hydrochloride 180 mg - film coated tablets - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria.

نورميتن ٢٥ إسرائيل - العربية - Ministry of Health

نورميتن ٢٥

abic ltd. - atenolol 25 mg - tablets - beta blocking agents, selective - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction.

تريتايس ٢٫٥ ملغ إسرائيل - العربية - Ministry of Health

تريتايس ٢٫٥ ملغ

sanofi - aventis israel ltd - ramipril 2.5 mg - tablets - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.